Integrated Single-Cell and Bulk RNA Sequencing Identifies SERPING1 as a Biomarker of Immune Infiltration and Prognosis in Triple-Negative Breast Cancer
Frontiers in Bioscience-Landmark · 2026
DOI: 10.31083/fbl47089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Yuhang Shang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, 150081 Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Biomarkers, Tumor, Serpins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Triple-negative breast cancer (TNBC) is an aggressive malignancy that lacks effective treatment. Immune infiltration plays an important role in anti-tumor responses. Serpin family G1 (SERPING1), a biomarker associated with immune infiltration, has been implicated in multiple cancers, but its role in TNBC remains unclear.
Methods
RNA sequencing and clinical data for TNBC were obtained from the Gene Expression Omnibus, the Cancer Genome Atlas, and the Molecular Taxonomy of Breast Cancer International Consortium databases. First, the expression, prognostic value, and biological functions of SERPING1 were analyzed. Then, the tumor microenvironment (TME) was comprehensively characterized, and the relationship between SERPING1 expression and immunotherapy response was assessed. Immunohistochemical staining was performed to confirm SERPING1 expression and the abundance of CD4+ T cells and CD8+ T cells in clinical specimens. Finally, single-cell analysis was conducted to investigate the role of SERPING1 in immune cell activation.
Results
SERPING1 was downregulated in TNBC and was an independent predictor of survival. Functionally, SERPING1 activated the immune response in TNBC patients. Mechanistically, elevated SERPING1 levels lead to increased immune cell infiltration, particularly of CD4+ and CD8+ T cells, in the TME. Moreover, SERPING1 was primarily localized in cancer-associated fibroblasts (CAFs), with SERPING1+ apCAFs exhibiting increased communications with anti-tumor immune cells at the single-cell level.
Conclusions
SERPING1 contributes to enhanced immune cell infiltration, desirable immunotherapy response, and improved prognosis. It thus can be utilized as a promising biomarker for immune infiltration and prognosis. These findings provide novel insights into TME-related immune regulation and may inform strategies to enhance immunotherapy efficacy in TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, 150081 Harbin, Heilongjiang, China.
- School of Basic Medicine, Harbin Medical University, 150081 Harbin, Heilongjiang, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shang, Y., Guo, R., Liu, J., Cheng, W., Hu, A., Liu, Y., Duan, Y., Wang, X., Fang, Z., Li, Y., Zhang, H., Li, M., Rong, Z., Ji, Y., Chen, Y., Cui, D., Ji, Y., & Guo, B. (2026). Integrated Single-Cell and Bulk RNA Sequencing Identifies SERPING1 as a Biomarker of Immune Infiltration and Prognosis in Triple-Negative Breast Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl47089
Vancouver
Shang Y, Guo R, Liu J, Cheng W, Hu A, Liu Y, et al. Integrated Single-Cell and Bulk RNA Sequencing Identifies SERPING1 as a Biomarker of Immune Infiltration and Prognosis in Triple-Negative Breast Cancer. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl47089
BibTeX
@article{Shang2026,
author = {Shang, Yuhang and Guo, Runze and Liu, Jiangwei and Cheng, Weilun and Hu, Anbang and Liu, Yansong and Duan, Yunqiang and Wang, Xuelian and Fang, Zhengbo and Li, Yanling and Zhang, Hanyu and Li, Mingcui and Rong, Zhiyuan and Ji, Yuanhao and Chen, Yulin and Cui, Delong and Ji, Yunyi and Guo, Baoliang},
title = {Integrated Single-Cell and Bulk RNA Sequencing Identifies SERPING1 as a Biomarker of Immune Infiltration and Prognosis in Triple-Negative Breast Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
doi = {10.31083/fbl47089}
}
EUVIMED